An Extension Study to WA19977 in Patients With Active Polyarticular-Course

Clinical Trial Summary

This long-term, interventional, open-label extension study will evaluate the safety and efficacy of RoActemra/Actemra (tocilizumab) in patients from Poland and Russia with polyarticular-course juvenile idiopathic arthritis who completed the WA19977 study. Patients will receive RoActemra/Actemra 8 mg/kg every 4 weeks. The anticipated time on study treatment is 104 weeks.

See also
Status	Clinical Trial	Phase
Completed	`NCT02776735` - An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)	Phase 2
Active, not recruiting	`NCT03092427` - Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)	N/A
Not yet recruiting	`NCT05545098` - MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
Not yet recruiting	`NCT03833609` - Yoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis	N/A
Completed	`NCT02524340` - Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
Recruiting	`NCT01434082` - Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis	N/A
Completed	`NCT04671524` - The Effect of Improvement in Function on Foot Pressure, Balance and Gait in Children With Upper Extremity Affected	N/A
Recruiting	`NCT04167488` - Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy	N/A
Recruiting	`NCT04205500` - Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis	N/A
Terminated	`NCT01694264` - Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα	Phase 3
Completed	`NCT02824978` - Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
Active, not recruiting	`NCT03841357` - Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)	Phase 3
Completed	`NCT03833271` - The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary	Early Phase 1
Completed	`NCT01455701` - A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)	Phase 1
Completed	`NCT05031104` - Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis	N/A
Not yet recruiting	`NCT01436019` - Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis	N/A
Recruiting	`NCT05609630` - Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3
Recruiting	`NCT05696340` - Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
Recruiting	`NCT05545839` - Transition to Adulthood Through Coaching and Empowerment in Rheumatology	N/A
Completed	`NCT05436301` - Turkish Validity and Reliability of Pain Catastrophizing Scale-Child (PCS-C)

NCT number	NCT01575769
Study type	Interventional
Source	Hoffmann-La Roche
Contact
Status	Terminated
Phase	Phase 3
Start date	January 19, 2012
Completion date	December 3, 2013

An Extension Study to WA19977 in Patients With Active Polyarticular-Course Juvenile Idiopathic Arthritis

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms